China International College Students’ Innovation Competition 2025 Finals Conclude in Zhengzhou

6 months ago

ZHENGZHOU, China, Oct. 20, 2025 /PRNewswire/ -- In a report published by Xinhua News Agency, the finals of the China International…

CoinLander Launches RWA Platform, Unlocking Stable Returns from Tokenized Real Estate Mortgages

6 months ago

Platform Democratizes Access to Real-World Asset (RWA) Investments, Merging Tangible Security with Blockchain Efficiency ROAD TOWN, British Virgin Islands, Oct.…

HTX Launches the “Sail Together” Initiative, Airdropping 100 Million USDT to Help Global Traders Weather Market Turbulence

6 months ago

PANAMA CITY, Oct. 20, 2025 /PRNewswire/ -- Rocked by the sudden "black swan event" on October 11, the crypto market experienced…

Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions

6 months ago

LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced today that it has successfully completed…

Missed out on gold and Bitcoin? RWA is creating a new batch of multi-millionaires!

6 months ago

London, UK, Oct. 19, 2025 (GLOBE NEWSWIRE) --  As global markets face inflation, falling interest rates, and economic uncertainty, investors…

From Economic Turbulence to a New Era of Wealth: NB HASH RWA Brings Real-World Assets On-Chain for Stable Digital Growth

6 months ago

London, UK, Oct. 19, 2025 (GLOBE NEWSWIRE) -- As global markets face inflation, currency depreciation, and rising uncertainty, investors are…

From Inflation to Innovation: How NB HASH and RWA Are Powering the Next Digital Wealth Boom

6 months ago

London, UK, Oct. 19, 2025 (GLOBE NEWSWIRE) -- As inflation pressures mount and global investors seek stable value amid currency…

Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION Platform at the European Society of Medical Oncology Annual Congress

6 months ago

October 19, 2025 10:00 ET  | Source: AVACTA GROUP PLC Median progression free survival (PFS) has not been reached in…

Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025

6 months ago

October 19, 2025 08:00 ET  | Source: Replimune, Inc. WOBURN, Mass., Oct. 19, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc.…

RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)

6 months ago

October 19, 2025 08:00 ET  | Source: RAPT Therapeutics, Inc. SOUTH SAN FRANCISCO, Calif., Oct. 19, 2025 (GLOBE NEWSWIRE) --…